Scarica l'app Stockscreener
7.31
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.31
Aprire:
$7.27
Volume 24 ore:
19,161
Relative Volume:
0.03
Capitalizzazione di mercato:
$1.07B
Reddito:
$342.81M
Utile/perdita netta:
$97.67M
Rapporto P/E:
11.90
EPS:
0.6145
Flusso di cassa netto:
$50.46M
1 W Prestazione:
+1.67%
1M Prestazione:
+7.98%
6M Prestazione:
-8.17%
1 anno Prestazione:
+5.94%
Intervallo 1D:
$7.20
$7.298
Intervallo di 1 settimana:
$7.01
$7.39
Portata 52W:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Nome
Mimedx Group Inc
Settore
Industria
Telefono
(770) 651-9100
Indirizzo
1775 W OAK COMMONS COURT, NE, MARIETTA
Confronta MDXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.6374 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.164 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.29 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Iniziato | Lake Street | Buy |
| 2023-10-27 | Iniziato | Craig Hallum | Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-07-26 | Iniziato | Northland Capital | Outperform |
| 2021-03-19 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Mimedx Group Inc Borsa (MDXG) Ultime notizie
MiMedx Group Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - Newser
Is MiMedx Group Inc. stock entering bullish territorySwing Trade & Expert Verified Stock Movement Alerts - Newser
Evaluating MiMedx Group Inc. with trendline analysisJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Why MiMedx Group Inc. is moving todayMarket Trend Report & Long-Term Capital Growth Ideas - Newser
Real time breakdown of MiMedx Group Inc. stock performanceEarnings Miss & Daily Volume Surge Trade Alerts - Newser
Sector ETF performance correlation with MiMedx Group Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - Newser
How to escape a deep drawdown in MiMedx Group Inc.Trade Risk Assessment & Consistent Growth Equity Picks - Newser
How MiMedx Group Inc. stock performs during market volatilityTrade Volume Report & Daily Market Momentum Tracking - Newser
Can MiMedx Group Inc. rally from current levelsMarket Rally & Verified Chart Pattern Signals - Newser
What makes MiMedx Group Inc. stock price move sharplyEarnings Performance Report & Free Community Supported Trade Ideas - Newser
Tools to monitor MiMedx Group Inc. recovery probabilityWeekly Earnings Recap & Long-Term Investment Growth Plans - Newser
Does MiMedx Group Inc. have consistent dividend growthJuly 2025 PostEarnings & Long-Term Investment Growth Plans - kangso.co.kr
Is MiMedx Group Inc. trending in predictive chart modelsJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Is MiMedx Group Inc. stock heavily shortedQuarterly Profit Summary & Fast Gaining Stock Reports - newsyoung.net
US Ophthalmology Amniotic Membrane Market to Reach $7.35B - openPR.com
Can you recover from losses in MiMedx Group Inc.AI Swing Strategy Signal Forecasting System - Newser
Zurcher Kantonalbank Zurich Cantonalbank Acquires 6,090 Shares of MiMedx Group, Inc (NASDAQ:MDXG) - Defense World
Full technical analysis of MiMedx Group Inc. stockAsset Safety Selection Using Quantitative Analysis - Newser
There May Be Reason For Hope In MiMedx Group's (NASDAQ:MDXG) Disappointing Earnings - Yahoo Finance
Clover Health and MiMedx Group Receive Bullish Analyst Sentiments - AInvest
Why MiMedx Group Inc. stock attracts strong analyst attentionShort Term High Yield Stock Tips for Active Traders - metal.it
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and MiMedx Group (MDXG) - The Globe and Mail
MiMedx Group Inc. Reports Record Earnings and Growth - TipRanks
MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter - MSN
Is MiMedx Group Inc. a good long term investmentFree Consultation - Jammu Links News
What drives MiMedx Group Inc. stock priceBuild wealth faster with consistent investment plans - Jammu Links News
Published on: 2025-08-04 04:52:32 - Jammu Links News
What are analysts’ price targets for MiMedx Group Inc. in the next 12 monthsHigh-yield investments - Jammu Links News
MiMedx Group Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News
When is MiMedx Group Inc. stock expected to show significant growthAchieve breakthrough financial results - Jammu Links News
Should I hold or sell MiMedx Group Inc. stock in 2025Consistently superior profits - Jammu Links News
What institutional investors are buying MiMedx Group Inc. stockCapitalize on high-yield stock opportunities - Jammu Links News
How does MiMedx Group Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News
What catalysts could drive MiMedx Group Inc. stock higher in 2025Free Investment Community - Jammu Links News
What is the dividend policy of MiMedx Group Inc. stockAchieve fast wealth growth with smart picks - Jammu Links News
Is it the right time to buy MiMedx Group Inc. stockMaximize gains with data-driven stock picks - Jammu Links News
What are the latest earnings results for MiMedx Group Inc.Achieve explosive financial results today - Jammu Links News
What is the risk reward ratio of investing in MiMedx Group Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
MiMedx Exceeds Q2 Revenue Expectations with Double-Digit Growth, Achieving Highest Quarterly Net Sales to Date. - AInvest
MiMedx Q2 2025 Earnings: EPS of $0.06 Beats Estimates, Revenue Hits $99 Million Surpassing Projections - AInvest
MiMedx Group Anticipates Improved EBITDA Margin for FY25, Projects Low Double-Digit Annual Net Sales Growth - AInvest
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2025 Earnings Call Transcript - Insider Monkey
MiMedx Group Reports Record Q2 2025 Financial Results - The Globe and Mail
MiMedx Group Inc. Achieves Impressive Q2 Financial ResultsNews and Statistics - IndexBox
Mimedx Group Inc Azioni (MDXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mimedx Group Inc Azioni (MDXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 17 '25 |
Sale |
8.04 |
1,759 |
14,142 |
309,077 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '25 |
Sale |
7.89 |
54,596 |
430,762 |
440,178 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 13 '25 |
Sale |
7.89 |
4,106 |
32,396 |
310,836 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '25 |
Sale |
7.80 |
81,446 |
635,279 |
494,774 |
1.29%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):